SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Quantitative measurement of anti-SARS-CoV-2 antibodies: Analytical and clinical evaluation

(2021) Victoria Higgins et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Timing of Rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis

(2021) Luca Quartuccio et al.   RHEUMATOLOGY

AB0596 THE POSSIBLE CONTRIBUTION OF DEHYDROEPIANDROSTERONE SULFATE FOR OSTEOARTHRITIS OF THE KNEE

(2021) I. Bashkova et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0540 COMPARISON OF EQ-5D HEALTH STATUS IN PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT AXIAL DISEASE: RESULTS OF SUBANALYSIS OF THE PATERA STUDY

(2021) I. Gaydukova et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0636 ASYMPTOMATIC HYPERURICEMIA IN INFLAMMATORY RHEUMATIC DISEASES

(2021) A. Fonturenko et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0577 METABOLIC SYNDROME IN PSORIATIC ARTHRITIS SEEMS ASSOCIATED TO INFLAMMATORY STATUS OF THE DISEASE

(2021) C. L. Iñíguez et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0641 EFFECT OF AGE ON PARATHYROID HORMONE RESPONSE TO VITAMIN D INSUFFICIENCY IN PRIMARY HYPERPARATHYROIDISM

(2021) V. Deshani et al.   ANNALS OF THE RHEUMATIC DISEASES

Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’

(2021) Chiara Salviani et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0549 PREDICTIVE FACTORS FOR SWITCHING IN PATIENTS WITH PSORIATIC ARTHRITIS UNDERGOING ANTI-TNFα, ANTI-IL12/23 OR ANTI-IL17 DRUGS: A FIFTEEN-YEAR MONOCENTRIC REAL-LIFE STUDY

(2021) M. Lorenzin et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0141 THE DYNAMICAL TRAJECTORY OF GLUCOCORTICOIDS TAPERING AND DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS COMMENCING GLUCOCORTICOIDS WITH CSDMARDS: A REAL-WORLD DATA FROM 2009 TO 2020

(2021) W. Xie et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

(2020) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia

(2020) Philippe Guilpain et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

(2020) Hendrik Schulze-Koops et al.   ANNALS OF THE RHEUMATIC DISEASES

Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

(2020) Phil‐Robin Tepasse et al.   BRITISH JOURNAL OF HAEMATOLOGY

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

(2020) David Simon et al.   Nature Communications

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial

(2018) Jin Kyun Park et al.   ANNALS OF THE RHEUMATIC DISEASES

Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank

(2018) Helmuth Haslacher et al.   BIOPRESERVATION AND BIOBANKING

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM